Active — Not RecruitingPhase 4

Latent Tuberculosis in Type 2 Diabetes

Taiwan552 participantsStarted 2018-04-18

Plain-language summary

The patients with poorly controlled DM underwent LTBI screening by using QuantiFERON (QFT). QFT-positivity predictors were evaluated. The patients with LTBI received tuberculosis preventive therapy, 9 months of daily isoniazid (9H) or 3 months of weekly rifapentine plus isoniazid (3HP), administered by pulmonologists. The completion rates and inflammatory markers were also investigated.

Who can participate

Age range45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged ≥45 years * poorly controlled DM (pDM), defined as HbA1c ≥9% within the preceding year Exclusion Criteria: * active TB * immunocompromise (use of immunosuppressors * current pregnancy

What they're measuring

Brain-Derived Neurotrophic Factor

Timeframe: 9 months

Trial details

NCT IDNCT06874725

SponsorTaichung Veterans General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Latent Tuberculosis Infection trials